Survey on Belgian Patients Suffering From Irregular Heartbeat and Starting Treatment With a Drug to Prevent Blood Clots in Blood Vessels and the Heart. This Study is Also Called BELANCOS.

CompletedOBSERVATIONAL
Enrollment

164

Participants

Timeline

Start Date

February 10, 2020

Primary Completion Date

November 30, 2020

Study Completion Date

December 31, 2020

Conditions
Atrial Fibrillation
Interventions
OTHER

Questionnaires

The survey will focus on non-valvular atrial fibrillation patients, who will start treatment with a NOAC, and their treating physician.

Trial Locations (1)

Unknown

Many locations, Multiple Locations

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Bayer

INDUSTRY